Tristel PLC

Tristel maintains a strong liquidity position with GBP 8.644 million in cash and equivalents, and a current ratio of 3.6, indicating a robust ability to cover short-term liabilities. The company's debt-to-equity ratio is 0.18, suggesting a conservative capital structure with limited leverage. Free cash flow is GBP 0.8 million, which is modest relative to operating cash flow of GBP 10.316 million, indicating some reinvestment in operations. Profitability metrics show a return on equity of 20.13% and a return on assets of 14.65%, both exceeding the industry median for medical equipment and supplies firms. Gross profit of GBP 37.459 million represents 80.6% of revenue, indicating strong pricing power or cost control. Operating income of GBP 8.397 million and net income of GBP 6.64 million suggest healthy margins, though the exact cohort median comparisons are not available in the input data. The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed in the input data. This lack of diversification may expose the company to regional economic or regulatory risks. No specific geographic revenue breakdown is provided, but the absence of multiple segments implies a single revenue stream. Tristel reported revenue of GBP 46.462 million in the latest period, with no prior-year data provided to assess growth. Analysts have set a mean price target of GBP 474.80, with a median of GBP 460.00, suggesting a generally positive outlook. The company's capital expenditure of GBP -1.982 million indicates some investment in operations, though the negative value may reflect a reduction in spending or a non-cash adjustment. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position reduce credit risk, but the lack of geographic or segment diversification could increase exposure to sector-specific downturns. No dilution pressure is currently expected, and the number of shares outstanding is stable between basic and diluted shares. Recent events include analyst price targets and recommendations, with a mean recommendation of 1.60 (favoring buy) and three strong-buy ratings. No recent filings or transcripts are provided in the input data to detail operational or strategic developments.